Vβ8+ T cells protect from demyelinating disease in a viral model of multiple sclerosis

被引:8
作者
Drescher, KM
Johnston, SL
Hogancamp, W
Nabozny, GH
David, CS
Rimm, IJ
Wettstein, PJ
Rodriguez, M
机构
[1] Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA
[3] Childrens Hosp, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
关键词
demyelination; Theiler's murine encephalomyelitis virus; Theiler's virus;
D O I
10.1093/intimm/12.3.271
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous studies illustrated the influence of T cell subsets on susceptibility or resistance to demyelination in the Theiler's murine encephalomyelitis virus (TMEV) model of multiple sclerosis. Genetic segregation analysis showed a correlation with disease phenotype in this model with particular V-beta genes. In this study we investigated the contribution of specific V-beta TCR to the pathogenesis of virus-induced demyelinating disease. Spectratype analysis of cells infiltrating the CNS early in infection demonstrated an over-representation of V(beta)8(+) T cells in mice expressing a susceptible H-2 haplotype. We infected transgenic mice expressing the V(beta)8.2 TCR directed against a non-TMEV antigen and found an increase in demyelinating disease in mice of either susceptible or resistant background compared with littermate controls. In addition, depletion studies with an anti-V(beta)8-specific antibody in both susceptible (B10.Q) and resistant (C57BL/6) mice resulted in increased demyelination. TCR analysis of VP2-specific cytotoxic T cell clones from mice with a resistant genotype identified only the V(beta)8.1 TCR, suggesting that limited T cell diversity is critical to TMEV clearance. Together, these results support a protective role for V(beta)8(+) T cells in virus-induced demyelinating disease.
引用
收藏
页码:271 / 280
页数:10
相关论文
共 54 条
  • [1] ArrunateguiCorrea V, 1997, ACTA VIROL, V41, P145
  • [2] FVB MICE TRANSGENIC FOR THE H-2D(B) GENE BECOME RESISTANT TO PERSISTENT INFECTION BY THEILERS VIRUS
    AZOULAY, A
    BRAHIC, M
    BUREAU, JF
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (06) : 4049 - 4052
  • [3] Brain-infiltrating cytolytic T lymphocytes specific for theiler's virus recognize H2D(b) molecules complexed with a viral VP2 peptide lacking a consensus anchor residue
    Borson, ND
    Paul, C
    Lin, XQ
    Nevala, WK
    Strausbauch, MA
    Rodriguez, M
    Wettstein, PJ
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (07) : 5244 - 5250
  • [4] MAPPING LOCI INFLUENCING THE PERSISTENCE OF THEILERS VIRUS IN THE MURINE CENTRAL-NERVOUS-SYSTEM
    BUREAU, JF
    MONTAGUTELLI, X
    BIHL, F
    LEFEBVRE, S
    GUENET, JL
    BRAHIC, M
    [J]. NATURE GENETICS, 1993, 5 (01) : 87 - 91
  • [5] Bureau JF, 1998, GENETICS, V148, P1941
  • [6] CAIGNARD A, 1994, CANCER RES, V54, P1292
  • [7] T-CELL RECEPTOR BETA-CHAIN USAGE IN MYELIN BASIC PROTEIN-SPECIFIC RAT LYMPHOCYTES-T
    CHLUBA, J
    STEEG, C
    BECKER, A
    WEKERLE, H
    EPPLEN, JT
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (02) : 279 - 284
  • [8] DECKHUT AM, 1993, J IMMUNOL, V151, P2658
  • [9] Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice
    Dethlefs, S
    Escriou, N
    Brahic, M
    vanderWerf, S
    LarssonSciard, EL
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (07) : 5361 - 5365
  • [10] DIETRICH PY, 1994, BLOOD, V84, P2815